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We would like to thank the author for detailing two additional pieces of literature related to aripiprazole and hiccups. As the author points out, a thorough review of the literature is crucial when it comes to building the association between medications and rare adverse events. Additionally, the author's letter provides us with worthy reminders for any publication. First, we do not know whether Hori and Nakamura's May 2014 publication was available when we submitted our final version to Journal of Pharmacy Practice also in May 2014. 1 However, we are reminded in this fast-paced arena of publishing and exponentially growing number of journals that even in the final phases of publication, ongoing literature searches should still be conducted. Second, a detailed evaluation of each report should be conducted to assess for any duplicate publication or report which later has been incorporated into a case series and published again. This is an unfortunate occurrence that we have encountered in the literature.
Currently, there appears to be a similar situation. The author suggests that we did not include a specific case report by Ginsberg, 2 but upon careful evaluation of this piece in Primary Psychiatry, Ginsberg is referencing the published case from Behere et al rather than describing an original case report. Ginsberg states ''There is now a report of aripiprazoleinduced hyponatremia'' (p. [19] [20] , and follows with the citation by Behere et al. This same case reported by Behere et al and referenced by Ginsberg is included in our case report. We summarize both Ginsberg's and Behere's publications in Table 1 . We wish to highlight this because each article has been cited multiple times in the literature and both have been cited within the same publication. 
